Comparative study of the neuroprotective effect of dehydroepiandrosterone and 17β-estradiol against 1-methyl-4-phenylpyridium toxicity on rat striatum

Neuroscience

Volumn 109, Issue 3, 2002, Pages 569-584

  Tomas Camardiel, M ^a   Sanchez Hidalgo, M C ^a   Sanchez del Pino, M J ^b   Navarro, A ^b   Machado, A ^a   Cano, J ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITY OF CÁDIZ   (Spain)

Author keywords

Dopamine; Glia; Glial fibrillary acidic protein; OX 6; Testosterone

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 5 HYDROXYINDOLEACETIC ACID; ACETYLCHOLINESTERASE; DOPAMINE; ESTRADIOL; GLIAL FIBRILLARY ACIDIC PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEUROPROTECTIVE AGENT; PRASTERONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SEROTONIN; TESTOSTERONE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOSE RESPONSE; ENZYME INHIBITION; FEMALE; IMMUNOHISTOCHEMISTRY; MICROGLIA; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; STRIATONIGRAL DEGENERATION; SYNAPTOSOME;

ACETYLCHOLINESTERASE; ANIMALS; DEHYDROEPIANDROSTERONE; DOPAMINE; DOWN-REGULATION; ESTRADIOL; FEMALE; GLIOSIS; IMMUNOHISTOCHEMISTRY; NEOSTRIATUM; NEURONS; NEUROPROTECTIVE AGENTS; PARKINSONIAN DISORDERS; RATS; RATS, WISTAR; TESTOSTERONE; TYROSINE 3-MONOOXYGENASE;

EID: 0037074891     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00502-4     Document Type: Article

References (102)

1. Protective effect of melatonin against the 1-methyl-4-phenylpyridinium-induced inhibition of complex I of the mitochondrial respiratory chain
2. Melatonin is protective against MPTP-induced striatal and hippocampal lesions
3. Melatonin, mitochondria, and cellular bioenergetics
4. Microglial response to 6-hydroxydopamine-induced substantia nigra lesions
5. Glial fibrillary acidic protein increases in the spinal cord of Lewis rats with acute experimental autoimmune encephalomyelitis
6. Expression of glial fibrillary acidic protein and neurofilament mRNA in gliosis induced by experimental autoimmune encephalomyelitis
7. Physical inactivity of murine retrovirus infected C57BL/6 mice is prevented by melatonin and dehydroepiandrosterone
8. Dehydroepiandrosterone pretreatment protects rats against the pro-oxidant and necrogenic effects of carbon tetrachloride
9. Dehydroepiandrosterone administration prevents the oxidative damage induced by acute hyperglycemia in rats
10. Dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress
11. Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats
12. Estrogen modulates responses of striatal dopamine neurons to MPP(+): Evaluations using in vitro and in vivo techniques
13. Recurrent hormone dependent chorea: Effects of oestrogens and progestogens
14. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage
15. Oestrogens and extrapyramidal system
16. Androstenediol and dehydroepiandrosterone protect mice against lethal bacterial infections and lipopolysaccharide toxicity
17. Comparison between pre- and postovulatory distributions of oestradiol and progesterone in the brain of the PMSG-treated rat
18. Protective effect of dehydroepiandrosterone against copper-induced lipid peroxidation in the rat
19. Dehydroepiandrosterone and its sulfated derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures
20. Ovariectomy and estradiol treatment affect the dopamine transporter and its gene expression in the rat brain
21. Implication of dopamine transporter system on 1-methyl-4-phenylpyridinium and rotenone effect in striatal synaptosomes
22. Bioenergetic and oxidative stress in neurodegenerative diseases
23. Dopamine neurons in pars compacta of the substantia nigra contain acetylcholinesterase: Histochemical correlations on the same brain section
24. Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice
25. Aetiology of Parkinson's disease
26. Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat
27. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats
28. 17Beta-estradiol antiinflammatory activity in carrageenin-induced pleurisy
29. Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model
30. An examination of male-female differences in progression and mortality of Parkinson's disease
31. DHEAS inhibits TNF production in monocytes, astrocytes and microglial cells
32. Use of in vitro superfusion to assess the dynamics of striatal dopamine clearance: Influence of estrogen
33. Inhibition of striatal dopamine transporter activity by 17beta-estradiol
34. Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice
35. Estrogen decreases corpus striatal neurotoxicity in response to 6-OHDA
36. Estrogen alters MPTP-induced neurotoxicity in female mice: Effects on striatal dopamine concentrations and release
37. Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice
38. Choline acetyltransferase and acetylcholinesterase containing projections from the basal forebrain to the amygdaloid complex of the rat
39. Protective effect of dehydroepiandrosterone against lipid peroxidation in a human liver cell line
40. Chorea associated with oral contraceptive therapy
41. Dehydroepiandrosterone, pregnenolone and sex steroids down-regulate reactive astroglia in the male rat brain after a penetrating brain injury
42. Microglia: Intrinsic immunoeffector cell of the brain
43. Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord
44. Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice
45. Dopaminergic toxicity after the stereotaxic administration of the 1-methyl-4-phenylpyridinium ion (MPP+) to rats
46. The epidemiology of estrogen replacement therapy and Alzheimer's disease
47. Glial cells and inflammation in Parkinson's disease: A role in neurodegeneration (Review)?
48. Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress
49. DHEA: A novel adjunct for the treatment of male trauma patients
50. Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats
51. Microglia and Alzheimer's disease
52. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity
53. Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
54. Microglia: A sensor for pathological events in the CNS
55. MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease
56. BDNF and NGF treatment in lesioned rats: Effects on cholinergic function and weight gain
57. The origin and nature of ramified and amoeboid microglia: A historical review and current concepts
58. Dehydroepiandrosterone protects muscle flap microcirculatory hemodynamics from ischemia/reperfusion injury: An experimental in vivo study
59. Protein measurement with the Folin phenol reagent
60. A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter
61. Melatonin as a therapeutic agent in experimental endotoxic shock
62. Neuroprotection by dehydroepiandrosterone-sulfate: Role of an NFkappaB-like factor
63. Risk of Parkinson's disease among first-degree relatives: A community-based study
64. Neurosteroid modulation of embryonic neuronal survival in vitro following anoxia
65. Rate of cell death in parkinsonism indicates active neuropathological process
66. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
67. Immune system response in Alzheimer's disease
68. Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures
69. The impact of gender and estrogen on striatal dopaminergic neurotoxicity
70. Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites
71. Effect of estradiol and progesterone on rat striatal dopamine uptake sites
72. Studies of dehydroepiandrosterone (DHEA) with the human estrogen receptor in yeast
73. Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
74. Mesencephalic type I astrocytes mediate the survival of substantia nigra dopaminergic neurons in culture
75. Steroid hormone regulation of antiviral immunity
76. Melatonin: A peroxyl radical scavenger more effective than vitamin E
77. Melatonin - A highly potent endogenous radical scavenger and electron donor: New aspects of the oxidation chemistry of this indole accessed in vitro
78. Prevention of 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced nitration of tyrosine hydroxylase and neurotoxicity by EUK-134, a superoxide dismutase and catalase mimetic, in cultured dopaminergic neurons
79. Interaction of 1-methyl-4-phenylpyridinium ion (MPP+) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase
80. Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons
81. Estrogen replacement therapy in older women: A neuropsychological and brain MRI study
82. Dopamine uptake by rat striatal synaptosomes: A compartmental analysis
83. Dehydroepiandrosterone, an endogenous immune modulator, after traumatic shock
84. Dehydroepiandrosterone and melatonin prevent Bacillus anthracis lethal toxin-induced TNF production in macrophages
85. Biochemistry of the neurotoxic action of MPTP: Or how a faulty batch of designer drug led to Parkinsonism in drug abusers
86. Reduction of MPP(+)-induced hydroxyl radical formation and nigrostriatal MPTP toxicity by inhibiting nitric oxide synthase
87. The brain's immune system
88. Oxygen free radical scavenger properties of dehydroepiandrosterone
89. Melatonin: A potent endogenous hydroxyl radical scavenger
90. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids
91. Effects of estrogen on the basal ganglia
92. Time course changes in the dopaminergic nigrostriatal system following transection of the medial forebrain bundle: Detection of oxidatively modified proteins in substantia nigra
93. In vivo protection of striatal dopaminergic system against 1-methyl-4-phenylpyridinium neurotoxicity by phenobarbital
94. Dehydroepiandrosterone inhibits lipopolysaccharide-induced nitric oxide production in BV-2 microglia
95. Differential activation of microglia after experimental spinal cord injury
96. Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline)
97. Vimentin immunoreactivity in normal and pathological human brain tissue
98. Replacement of DHEA in aging men and women. Potential remedial effects. Dehydroepiandrosterone (DHEA) and aging
99. Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice
100. Prevention of immune dysfunction and vitamin E loss by dehydroepiandrosterone and melatonin supplementation during murine retrovirus infection
101. Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain